Skip to content

Author

A. Kornietskaya

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

The role of CDK4/6 inhibitors in the treatment of luminal HER2/neu-negative early breast cancer

Cyclin-dependent kinase 4/6 (CDK4/6) inhibitors have become an integral component of both international and national treatment guidelines for patients with hormone receptor-positive (HR-positive), HER2-negative metastatic breast cancer. This review aimed to summarize current evidence on the efficacy of palbociclib, r...

P. D. Potselueva, S. Evdokimova, A. Kornietskaya · 0 citations
Open access Sep 2026

First-line immunotherapy for patients with metastatic non-small cell lung cancer not eligible for a platinum-based chemotherapy

Immune checkpoint inhibitors alone or in combination with platinum-based doublet chemotherapy is the standard first-line treatment for patients with metastatic non-small cell lung cancer (mNSCLC) without driver mutations. It should be recognized, however, that treating patients who are not eligible for platinum-based c...

A. Kornietskaya, S. Evdokimova, N. S. Prizova et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.